Skip to content

Optic Nerve Sheath Diameter Changes in Laparoscopic Cholecystectomy

Impact of Intra-abdominal Pressure on Optic Nerve Sheath Diameter During Laparoscopic Cholecystectomy: A Randomized Prospective Study

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT07162922
Enrollment
76
Registered
2025-09-09
Start date
2025-09-17
Completion date
2025-12-21
Last updated
2025-12-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Increased Intracranial Pressure Disorders, Perioperative Complication, Pneumoperitoneum

Keywords

optic nerve sheath,, ultrasonography,, cholesistectomy,, pneumoperitoneum

Brief summary

Purpose The goal of this clinical trial is to learn how different intra-abdominal pressures during laparoscopic cholecystectomy affect the optic nerve sheath diameter (ONSD), which is a non-invasive marker of intracranial pressure. The study will also evaluate whether these changes are related to symptoms such as headache, confusion, and nausea after surgery. Study Design This is a prospective, randomized, double-blind clinical trial. Patients undergoing elective laparoscopic cholecystectomy will be assigned to one of two groups: Group 1: pneumoperitoneum at 8 mmHg Group 2: pneumoperitoneum at 14 mmHg ONSD will be measured at several time points before, during, and after surgery using transorbital ultrasonography.

Detailed description

Purpose The aim of this clinical trial is to investigate how different intra-abdominal pressures applied during laparoscopic cholecystectomy affect the optic nerve sheath diameter (ONSD), which serves as a reliable, non-invasive marker of intracranial pressure. The study also seeks to determine whether perioperative ONSD changes are associated with postoperative symptoms such as headache, nausea, and disorientation, as well as with recovery parameters and hemodynamic stability. Study Design This is a prospective, randomized, double-blind, interventional clinical trial. Eligible patients scheduled for elective laparoscopic cholecystectomy will be randomized into two groups based on pneumoperitoneum pressure: Group 1 (Low-pressure group): pneumoperitoneum maintained at 8 mmHg Group 2 (High-pressure group): pneumoperitoneum maintained at 14 mmHg ONSD will be measured via transorbital ultrasonography at standardized perioperative time points: T0: Before induction of anesthesia T1: 30 minutes after initiation of pneumoperitoneum T2: 5 minutes after extubation T3: 1 hour postoperatively T4: 2 hours postoperatively All ultrasonographic assessments will be performed by a trained investigator blinded to the patient's group allocation. Participation Patients will receive anesthesia and undergo laparoscopic cholecystectomy according to standard surgical protocols. Each participant will be randomly assigned to one of the two pneumoperitoneum pressure groups (8 mmHg or 14 mmHg). After surgery, patients will be observed in the recovery unit. Postoperative symptoms including headache, nausea and vomiting will be recorded.

Interventions

OTHER8 mmHg pressure group

Laparoscopic cholecystectomy will be performed with intra-abdominal pressure maintained at 8 mmHg during insufflation. Standard anesthesia and surgical protocols will be followed.

OTHER14 mmHg pressure group

Laparoscopic cholecystectomy will be performed with intra-abdominal pressure maintained at 14 mmHg during insufflation. Standard anesthesia and surgical protocols will be followed.

Sponsors

Engin Çetin
Lead SponsorOTHER_GOV

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
DIAGNOSTIC
Masking
QUADRUPLE (Subject, Caregiver, Investigator, Outcomes Assessor)

Intervention model description

Parallel Assignment

Eligibility

Sex/Gender
ALL
Age
18 Years to 65 Years
Healthy volunteers
No

Inclusion criteria

* 18-65 years of age * ASA physical status I-II * BMI \< 30 kg/m² * Scheduled for elective laparoscopic cholecystectomy

Exclusion criteria

* Known neurological diseases * Ocular pathology * History of elevated intracranial pressure (ICP) * Pregnancy * Need for emergency surgery

Design outcomes

Primary

MeasureTime frameDescription
Effects of Pneumoperitoneum Pressure on ONSD Over TimeT0: Before intubation T1: 30 minutes after the initiation of pneumoperitoneum T2: 5 minutes after extubation T3: 1 hour after extubation T4: 2 hours after extubationTo compare the effect of two different pneumoperitoneum pressures (8 mmHg vs. 14 mmHg) on optic nerve sheath diameter (ONSD) during laparoscopic cholecystectomy. ONSD will be assessed by measuring changes with transorbital ultrasonography at multiple perioperative time points

Secondary

MeasureTime frameDescription
Number of participants with postoperative nausea assessed by a standardized 4-point nausea scaleOne hour after surgeryPostoperative nausea will be assessed one hour after surgery using a standardized 4-point scale (0 = no nausea, 1 = mild, 2 = moderate, 3 = severe). The number and proportion of participants with any nausea (score ≥1) will be recorded. Higher scores indicate worse symptoms.
Number of participants with postoperative vomiting within one hour after surgeryOne hour after surgeryOccurrence of vomiting will be recorded during the first postoperative hour. The number and percentage of participants experiencing at least one vomiting episode will be documented (yes/no outcome)
Severity of postoperative headache assessed by Numerical Rating Scale (NRS, 0-10)One hour after surgeryPostoperative headache will be evaluated one hour after surgery using a Numerical Rating Scale (NRS), where 0 = no pain and 10 = worst possible pain. Mean NRS scores and the proportion of participants with moderate-to-severe headache (NRS ≥4) will be reported. Higher scores indicate more severe pain.

Countries

Turkey (Türkiye)

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Mar 21, 2026